Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database

被引:0
|
作者
Mansour Tobaiqy
Hajer Elkout
机构
[1] University of Jeddah,Department of Pharmacology, College of Medicine
[2] University of Tripoli,Department of Family and Community Medicine, Medical Faculty
关键词
Liraglutide; Obesity; Psychiatric adverse events; Semaglutide; Suicide; Tirzepatide;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:488 / 495
页数:7
相关论文
共 50 条
  • [21] Ocular Adverse Events Associated with Platins: A Disproportionality Analysis of Pharmacovigilance Data and Extensive Systematic Review of Case Reports
    Hasik, P. N.
    Thomas, Christy
    Undela, Krishna
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 176 - 176
  • [22] Ocular adverse events associated with platins: a disproportionality analysis of pharmacovigilance data and extensive systematic review of case reports
    Hasik, P. N.
    Thomas, Christy
    Hazarika, Munlima
    Undela, Krishna
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [23] Adverse events associated with the use of complementary medicine and health supplements: An analysis of reports in the Singapore Pharmacovigilance database from 1998 to 2009
    Patel, Dhavalkumar Narendrabhai
    Low, Wai-Ling
    Tan, Libei Liesbet
    Tan, Mui-Mui Belinda
    Zhang, Qian
    Low, Min-Yong
    Chan, Cheng-Leng
    Koh, Hwee-Ling
    CLINICAL TOXICOLOGY, 2012, 50 (06) : 481 - 489
  • [24] Ophthalmic adverse events under tofacitinib and baricitinib: Case analysis of the European Pharmacovigilance Database
    Hecquet, Sophie
    Rabier, Marie-Blanche Valnet
    Lepelley, Marion
    Verhoeven, Frank
    Delbosc, Bernard
    Avouac, Jerome
    Prati, Clement
    Gauthier, Anne-Sophie
    Wendling, Daniel
    JOINT BONE SPINE, 2023, 90 (01)
  • [25] Fluoroquinolones-related psychiatric adverse events: a real-world retrospective and pharmacovigilance database analysis
    Li, JuanJuan
    Yin, Xiaohong
    Zhao, Yang
    Yang, Xueqin
    Wang, Jing
    Yuan, Ting
    Zheng, Juan
    Tang, Qian
    Wei, Wei
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [26] Psychiatric disorders associated with fluoroquinolones: a pharmacovigilance analysis of the FDA adverse event reporting system database
    Xie, Wen-Long
    Ge, Meng-Lan
    Chen, Dan
    Chen, Guo-Qing
    Mei, Yuan-Xi
    Lai, Yong-Ji
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [27] Influence of rapidly increased numbers of reports on adverse events of the COVID-19 vaccine in the Japanese pharmacovigilance database on disproportionality analysis of antineoplastic drug-associated adverse cardiovascular events
    Matsuo, Hajime
    Tanaka, Hiroyuki
    Endo, Kiri
    Ishii, Toshihiro
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [28] Neuropsychological adverse drug reactions of Remdesivir: analysis using VigiBase, the WHO global database of individual case safety reports
    Lee, S.
    Yang, J. W.
    Jung, S. Y.
    Kim, M. S.
    Yon, D. K.
    Lee, S. W.
    Kang, H-C
    Dragioti, E.
    Tizaoui, K.
    Jacob, L.
    Koyanagi, A.
    Salem, J-E
    Kostev, K.
    Lascu, A.
    Shin, J., I
    Kim, J. H.
    Smith, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (23) : 7390 - 7397
  • [29] Safety case reports analysis of progestin-only contraceptives within the French Pharmacovigilance Database
    Grandvuillemin, A.
    Boulay, A.
    Luu, M.
    Delaunay, P.
    Gouverneur, A.
    Benevent, J.
    Dautriche, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 57 - 57
  • [30] First generation antipsychotic-associated serious adverse events in women: a retrospective analysis of a pharmacovigilance database
    McCall, Kenneth L.
    Doughty, Bennett J.
    Piper, Brian J.
    Naik, Heeral
    Bange, Seraphine
    Leppien, Emily E.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024, 46 (02) : 515 - 521